✦ LIBER ✦

gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma

✍ Scribed by Schwartzentruber, Douglas J.; Lawson, David H.; Richards, Jon M.; Conry, Robert M.; Miller, Donald M.; Treisman, Jonathan; Gailani, Fawaz; Riley, Lee; Conlon, Kevin; Pockaj, Barbara; Kendra, Kari L.; White, Richard L.; Gonzalez, Rene; Kuzel, Timothy M.; Curti, Brendan; Leming, Phillip D.; Whitman, Eric D.; Balkissoon, Jai; Reintgen, Douglas S.; Kaufman, Howard; Marincola, Francesco M.; Merino, Maria J.; Rosenberg, Steven A.; Choyke, Peter; Vena, Don; Hwu, Patrick

Book ID: 121838827
Publisher: Massachusetts Medical Society
Year: 2011
Tongue: English
Weight: 510 KB
Volume: 364
Category: Article
ISSN: 0096-6762
DOI: 10.1056/NEJMoa1012863

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effects of gp100 and tyrosinase pept

The effects of gp100 and tyrosinase peptide vaccinations on nevi in melanoma patients

✍ David S. Cassarino; ; Aaron Auerbach; Aparche Yang; Richard Sherry; Paul H. Dura 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Wild-type and modified gp100 peptide-pul

Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used

✍ W. Joost Lesterhuis; Gerty Schreibelt; Nicole M. Scharenborg; H. Mary-lène H. Br 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 352 KB

Synergistic effect of a combined DNA and

Synergistic effect of a combined DNA and peptide vaccine against gp100 in a malignant melanoma mouse model

✍ Michael Nawrath; Jovan Pavlovic; Karin Moelling 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 175 KB

Safety profile of histamine dihydrochlor

Safety profile of histamine dihydrochloride administered with interleukin-2 in patients with advanced metastatic malignant melanoma

✍ S.J. O'Day; J. Glaspy; E. Whitman; C.L. Kass; K.R. Gehlsen; S.S. Agarwala 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Phase I/II trial of a dendritic cell vac

Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma

✍ Steele, J C; Rao, A; Marsden, J R; Armstrong, C J; Berhane, S; Billingham, L J; 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 661 KB

Heterogeneity in CD8+ T cell responses t

Heterogeneity in CD8+ T cell responses to MAGE-3, Melan A/MART-1, GP100, tyrosinase, MSH and TRP-2 in vaccine-treated patients with melanoma

✍ Reynolds, Sandra J.; Celis, Esteban; Sette, Alessandro; Shapiro, Richard; Oratz, 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 167 KB